BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/25/2025 7:59:10 AM | Browse: 2 | Download: 0
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Basic Study |
| Article Title |
SLC30A8 promoter hypermethylation is associated with type 2 diabetes and diabetic kidney disease in a Chinese population
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nan Li, Yu-Peng Li, Qing Xu, Jian Xu, Yi-Hong Yu, Juan Su, Chong Shen, Jiang-Yi Yu and Harvest F Gu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Excellent Doctor Program of Jiangsu Province Hospital of Chinese Medicine |
20221222 |
| Launch Grant of China Pharmaceutical University |
20180815 |
|
| Corresponding Author |
Harvest F Gu, Laboratory of Molecular Medicine, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, No. 24 Tongjia Alley, Gulou District, Nanjing 210009, Jiangsu Province, China. feng.gu@cpu.edu.cn |
| Key Words |
Diabetic kidney disease; DNA methylation; Solute carrier family 30 member 8; Type 2 diabetes; Hypermethylation |
| Core Tip |
Solute carrier family 30 member 8 (SLC30A8) is a β-cell specific Zn transporter in insulin secretory granules. DNA in the SLC30A8 gene promoter region is hypermethylated. SLC30A8 promoter hypermethylation is associated with both type 2 diabetes and diabetic kidney disease. This study aims to evaluate whether DNA methylation changes in SLC30A8 is associated with type 2 diabetes and diabetic kidney disease. |
| Citation |
Li N, Li YP, Xu Q, Xu J, Yu YH, Su J, Shen C, Yu JY, Gu HF. SLC30A8 promoter hypermethylation is associated with type 2 diabetes and diabetic kidney disease in a Chinese population. World J Diabetes 2025; In press |
 |
Received |
|
2025-09-08 06:24 |
 |
Peer-Review Started |
|
2025-09-12 00:15 |
 |
First Decision by Editorial Office Director |
|
2025-10-23 08:13 |
 |
Return for Revision |
|
2025-10-23 08:13 |
 |
Revised |
|
2025-10-25 10:36 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-18 02:52 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-25 07:59 |
 |
Articles in Press |
|
2025-12-25 07:59 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345